Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2021

13 - 14 Oct 2021


Slides and Webcasts from all ESMO Advanced Courses are open to all ESMO account holders, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives
  • Understanding the function and biology of KRAS in normal and malignant cells
  • Gaining insights in the spectrum of KRAS molecular aberrations, platforms and strategies for molecular testing
  • In depth discussion of emerging therapeutic strategies and clinical research in KRAS mutated NSCLC
  • Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of KRAS G12C inhibition and beyond

This event has been supported by an unrestricted educational grant from AMGEN.

Filter by:

There are 16 resources available

Impact of Co-mutations

Presenter: F. Skoulidis, US

Session: Session 1 – KRAS Biology, Epidemiology, Pathology




This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.